Vasomotor Symptom
Top in women’s health: Future of mifepristone; Biden invests in women’s health research
On March 26, the Supreme Court heard oral arguments regarding the accessibility, efficacy and safety of mifepristone, a drug commonly used for medication abortion.
Non-hormone drugs can reduce menopausal hot flash frequency, severity
Fezolinetant and elinzanetant are both promising nonhormone therapies for managing vasomotor symptoms among postmenopausal women, with favorable safety profiles for up to 12 weeks, according to a systematic review published in Menopause.
Migraine plus persistent vasomotor symptoms linked to greater stroke, CVD risks
Migraine plus persistent vasomotor symptoms is associated with greater CVD risk and stroke for women, according to a secondary data analysis published in Menopause.
Purified pollen extract efficacy uncertain, but likely safe in reducing vasomotor symptoms
The therapeutic efficacy of purified pollen extract in reducing vasomotor and other perimenopausal symptoms is questionable, but is likely safe, according to a systematic review and meta-analysis published in Menopause.
Top in women’s health: Updates on hot flash treatments, postpartum hypertension
Fezolinetant performed better than other nonhormonal medications at reducing vasomotor symptoms due to menopause, according to a recent meta-analysis of randomized studies.
Elinzanetant’s impact on vasomotor symptoms prompts study on menopausal sleep disturbances
Following positive topline data for moderate to severe vasomotor symptom treatment, a phase 2 study of elinzanetant is underway to assess its safety and efficacy on sleep disturbances associated with menopause, Bayer said in a news release.
Fezolinetant associated with reduced hot flash frequency vs. other nonhormone therapies
Fezolinetant 45 mg once daily was statistically significantly more effective in reducing moderate to severe vasomotor symptom frequency compared with other nonhormonal — but not hormone-based — therapies in the U.S., researchers reported.
Reduced menopause symptoms with herbal supplement vs. hormone therapy
An oral herbal supplement with glucosinolates, phytosterols and citrus flavonoids was associated with some improved menopausal symptoms short term compared with estrogen plus progestogen therapy, researchers reported in Menopause.
Survey: 42% of midlife women have used cannabis, 6% for menopause symptoms
PHILADELPHIA — Medical and recreational cannabis use by midlife women may be “relatively common,” with 6% of those who report use saying they use the drug to address symptoms of menopause, according to a speaker.
Women with obesity report more menopausal symptoms, less relief with HT
PHILADELPHIA — In a small study, more women with obesity reported vasomotor, genitourinary, mood and libido symptoms associated with menopause than their peers without obesity, according to a presenter.